Company Filing History:
1 out of 328 
1 out of 1 
1 out of 41 Years Active: 1993-2019
Title: Jerzy Kazimierz Konopa: Innovator in Antitumor Pharmaceuticals
Introduction
Jerzy Kazimierz Konopa is a notable inventor based in Gdansk, Poland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor activity. With a total of 4 patents to his name, Konopa's work has the potential to impact cancer treatment significantly.
Latest Patents
One of his latest patents is titled "Asymmetric bis-acridines with antitumour activity and their uses." This invention discloses novel asymmetric bis-acridines that exhibit antitumor activity, making them useful in pharmaceuticals for the treatment or prevention of neoplasms. Another significant patent is "1-nitroacridine/tumor inhibitor compositions." This invention focuses on 1-nitroacridine derivative(s) and tumor inhibitor(s) compositions, along with methods for using these compositions to inhibit or prevent tumor growth, particularly prostate cancer cell growth and metastases.
Career Highlights
Throughout his career, Jerzy Kazimierz Konopa has worked with various organizations, including the British Technology Group Limited. His innovative work in the pharmaceutical sector has garnered attention and respect within the scientific community.
Collaborations
Konopa has collaborated with notable individuals such as Raj Tiwari and Barbara Wysocka-Skrzela. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jerzy Kazimierz Konopa is a distinguished inventor whose work in antitumor pharmaceuticals holds promise for future cancer treatments. His innovative patents and collaborations reflect his commitment to advancing medical science.